VandanaB.SharmaMDPhD(She/Her)
Oncology • Fort Bragg, CACancer Genetics/Cancer Risk Assessment, Hematologic Oncology
Fort Bragg, CA
Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 River Drive
Fort Bragg, CA 95437Phone+1 707-961-4965
Education & Training
Stanford Health CarePost-Doctoral Fellowship, 2005 - 2007- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2002 - 2005
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1999 - 2002
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Clinical Trials
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples Start of enrollment: 2001 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsCBP Is a Dosage-Dependent Regulator of Nuclear Factor-κB Suppression by the Estrogen ReceptorKendall W. Nettles, German Gil, Jason Nowak, Raphaël Métivier, Vandana B. Sharma
Molecular Endocrinology. 2008-02-01 - 112 citationsDefective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.Elizabeth Alli, Vandana B. Sharma, Preethi Sunderesakumar, James M. Ford
Cancer Research. 2009-04-15 - 35 citationsEnhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cellsElizabeth Alli, Vandana B. Sharma, Anne-Renee Hartman, Patrick S. Lin, Lisa A. McPherson
BMC Pharmacology. 2011-07-19
Professional Memberships
- Member
Other Languages
- Spanish, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
